Uploaded June 2026 | Updated September 2026, 22 hours ago
Retatrutide is the investigational triple-hormone drug (GLP-1 + GIP + glucagon) posting some
of the largest weight-loss numbers ever recorded in trials. Here's what it actually is, how it
differs from Ozempic and Mounjaro, and what the science really shows — no hype
In this video we break down:
• What retatrutide is and how a triple-receptor agonist works
• How it compares to GLP-1 (semaglutide) and GLP-1/GIP (tirzepatide) drugs
• What the Phase 3 TRIUMPH trial results show on weight loss
• Where it stands on FDA approval and what's realistic on timing
• What's hype vs. what's actually established science
⏱️ Chapters
00:00 Intro — why retatrutide is making headlines
00:45 What is retatrutide? (the basics)
02:30 How a triple-hormone receptor agonist works
05:00 Retatrutide vs Ozempic vs Mounjaro
08:00 What the Phase 3 trial data actually shows
11:00 FDA approval status & realistic timeline
13:30 Fact vs. hype — the honest takeaway
📌 The research: azoth-peptides.com/research-catalog/azoth/27
📚 The education: peptidepressure.io
⚠️ This video is for education only and is not medical advice. Retatrutide is an
investigational drug that is not FDA-approved; it is not currently available by prescription
and cannot be legally purchased or compounded. Talk to a licensed physician before making any
health decisions.
Retatrutide is the investigational triple-hormone drug (GLP-1 + GIP + glucagon) posting some
of the largest weight-loss numbers ever recorded in trials. Here's what it actually is, how it
differs from Ozempic and Mounjaro, and what the science really shows — no hype
In this video we break down:
• What retatrutide is and how a triple-receptor agonist works
• How it compares to GLP-1 (semaglutide) and GLP-1/GIP (tirzepatide) drugs
• What the Phase 3 TRIUMPH trial results show on weight loss
• Where it stands on FDA approval and what's realistic on timing
• What's hype vs. what's actually established science
⏱️ Chapters
00:00 Intro — why retatrutide is making headlines
00:45 What is retatrutide? (the basics)
02:30 How a triple-hormone receptor agonist works
05:00 Retatrutide vs Ozempic vs Mounjaro
08:00 What the Phase 3 trial data actually shows
11:00 FDA approval status & realistic timeline
13:30 Fact vs. hype — the honest takeaway
📌 The research: azoth-peptides.com/research-catalog/azoth/27
📚 The education: peptidepressure.io
⚠️ This video is for education only and is not medical advice. Retatrutide is an
investigational drug that is not FDA-approved; it is not currently available by prescription
and cannot be legally purchased or compounded. Talk to a licensed physician before making any
health decisions.
